DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Dilantin-125 (Phenytoin) - Toxic Epidermal Necrolysis - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Toxic Epidermal Necrolysis (9)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dilantin-125 (Phenytoin) where reactions include toxic epidermal necrolysis. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Dilantin-125 side effects in female

Reported by a lawyer from United States on 2012-07-31

Patient: female

Reactions: Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dilantin
    Dosage: 1 g, unk
    Indication: Convulsion
    Start date: 2011-01-12
    End date: 2011-01-12

Dilantin
    Dosage: 100 mg, 4x/day
    Start date: 2011-01-12
    End date: 2011-01-12

Dilantin
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Start date: 2011-01-13
    End date: 2011-01-13

Dilantin
    Dosage: 50mg infatabs twice daily along with phenytoin 200mg capsules to make total daily dose of 500mg
    Administration route: Oral
    Start date: 2011-01-14

Dilantin
    Dosage: 200mg capsules twice daily along with phenytoin infatabs 50mg to make total daily dose of 500mg
    Administration route: Oral
    Start date: 2011-01-14

Dilantin-125
    Dosage: unk
    Indication: Convulsion
    Start date: 2010-12-01



Possible Dilantin-125 side effects in female

Reported by a lawyer from United States on 2012-07-25

Patient: female

Reactions: Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dilantin
    Dosage: 50 mg, unk
    Start date: 2001-01-01

Dilantin
    Dosage: 100 mg, unk
    Start date: 2001-01-01

Dilantin
    Dosage: 300 mg, unk
    Start date: 2001-11-02
    End date: 2001-11-06

Dilantin-125
    Dosage: unk
    Administration route: Oral
    Indication: Intracranial Aneurysm
    Start date: 2001-01-01

Phenytoin Sodium
    Dosage: 250 mg, every twelve hours
    Start date: 2001-10-22
    End date: 2001-11-02

Phenytoin Sodium
    Dosage: 100mg, 2 ml
    Start date: 2001-01-01

Phenytoin Sodium
    Dosage: 100 mg, every eight hours
    Start date: 2001-10-18
    End date: 2001-10-25

Phenytoin Sodium
    Dosage: 250 mg, 5 ml
    Start date: 2001-01-01



Possible Dilantin-125 side effects in female

Reported by a lawyer from United States on 2012-07-20

Patient: female

Reactions: Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dilantin
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Start date: 2011-01-13
    End date: 2011-01-13

Dilantin
    Dosage: 1 g, unk
    Indication: Convulsion
    Start date: 2011-01-12
    End date: 2011-01-12

Dilantin
    Dosage: 50mg infatabs twice daily along with phenytoin 200mg capsules to make total daily dose of 500mg
    Administration route: Oral
    Start date: 2011-01-14

Dilantin
    Dosage: 100 mg, 4x/day
    Start date: 2011-01-12
    End date: 2011-01-12

Dilantin
    Dosage: 200mg capsules twice daily along with phenytoin infatabs 50mg to make total daily dose of 500mg
    Administration route: Oral
    Start date: 2011-01-14

Dilantin-125
    Dosage: unk
    Indication: Convulsion
    Start date: 2010-12-01



Possible Dilantin-125 side effects in male

Reported by a lawyer from United States on 2012-07-17

Patient: male

Reactions: Acute Generalised Exanthematous Pustulosis, Toxic Epidermal Necrolysis, Drug Rash With Eosinophilia and Systemic Symptoms, Stevens-Johnson Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cerebyx
    Dosage: unk
    Start date: 2009-10-01

Dilantin-125
    Dosage: unk
    Administration route: Oral
    Indication: Convulsion
    Start date: 2009-10-01



Possible Dilantin-125 side effects in female

Reported by a lawyer from United States on 2012-07-09

Patient: female

Reactions: Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dilantin
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Start date: 2011-01-13
    End date: 2011-01-13

Dilantin
    Dosage: 1 g, unk
    Indication: Convulsion
    Start date: 2011-01-12
    End date: 2011-01-12

Dilantin
    Dosage: 200mg capsules twice daily along with phenytoin infatabs 50mg to make total daily dose of 500mg
    Administration route: Oral
    Start date: 2011-01-14

Dilantin
    Dosage: 50mg infatabs twice daily along with phenytoin 200mg capsules to make total daily dose of 500mg
    Administration route: Oral
    Start date: 2011-01-14

Dilantin
    Dosage: 100 mg, 4x/day
    Start date: 2011-01-12
    End date: 2011-01-12

Dilantin-125
    Dosage: unk
    Indication: Convulsion
    Start date: 2010-12-01



Possible Dilantin-125 side effects in female

Reported by a lawyer from United States on 2012-03-27

Patient: female

Reactions: Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dilantin
    Dosage: 1 g, unk
    Indication: Convulsion
    Start date: 2011-01-12
    End date: 2011-01-12

Dilantin
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Start date: 2011-01-13
    End date: 2011-01-13

Dilantin
    Dosage: 100 mg, 4x/day
    Start date: 2011-01-12
    End date: 2011-01-12

Dilantin
    Dosage: 50mg infatabs twice daily along with phenytoin 200mg capsules to make total daily dose of 500mg
    Administration route: Oral
    Start date: 2011-01-14

Dilantin
    Dosage: 200mg capsules twice daily along with phenytoin infatabs 50mg to make total daily dose of 500mg
    Administration route: Oral
    Start date: 2011-01-14

Dilantin-125
    Dosage: unk
    Indication: Convulsion
    Start date: 2010-12-01



Possible Dilantin-125 side effects in male

Reported by a lawyer from United States on 2012-03-08

Patient: male

Reactions: Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome

Drug(s) suspected as cause:
Dilantin-125



Possible Dilantin-125 side effects in female

Reported by a lawyer from United States on 2012-01-31

Patient: female

Reactions: Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dilantin
    Dosage: 50 mg, unk
    Start date: 2001-01-01

Dilantin
    Dosage: 100 mg, unk
    Start date: 2001-01-01

Dilantin
    Dosage: 300 mg, unk
    Start date: 2001-11-02
    End date: 2001-11-06

Dilantin-125
    Dosage: unk
    Administration route: Oral
    Indication: Intracranial Aneurysm
    Start date: 2001-01-01

Phenytoin Sodium
    Dosage: 250 mg, 5 ml
    Start date: 2001-01-01

Phenytoin Sodium
    Dosage: 100 mg, every eight hours
    Start date: 2001-10-18
    End date: 2001-10-25

Phenytoin Sodium
    Dosage: 100mg, 2 ml
    Start date: 2001-01-01

Phenytoin Sodium
    Dosage: 250 mg, every twelve hours
    Start date: 2001-10-22
    End date: 2001-11-02



Possible Dilantin-125 side effects in female

Reported by a lawyer from United States on 2011-11-15

Patient: female

Reactions: Toxic Epidermal Necrolysis, Amnesia, Finger Amputation, Skin Necrosis, Stevens-Johnson Syndrome, Soft Tissue Necrosis, Scar, Blister

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cerebyx
    Dosage: unk
    Indication: Convulsion

Dilantin-125
    Dosage: unk

Fosphenytoin
    Dosage: unk
    Indication: Convulsion
    Start date: 2009-09-15
    End date: 2009-09-23

Tamiflu
    Dosage: unk

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017